Impetigo Treatment Online in California

Yes. California Business and Professions Code Section 2290.5 permits California-licensed physicians to deliver care via synchronous video telehealth. TeleDirectMD physicians are licensed in California and follow AAD and IDSA SSTI guidelines for impetigo management. Adults 18+ in California with honey-colored crusted or vesicular skin lesions can book a same-day video visit — the physician evaluates the affected area on camera and prescribes topical mupirocin or oral antibiotics when appropriate. Self pay is $79; Aetna is in-network as of April 30, 2026.

Non-bullous impetigo (the most common form) presents as small red sores that rupture, ooze, and form characteristic honey-colored or golden-brown crusts, typically on the face — around the nose and mouth — or on the arms and legs. Bullous impetigo causes larger fluid-filled blisters (bullae) that rupture to leave a reddish raw surface. The rash is usually not painful but can be itchy. Diagnosis is typically clinical — based on appearance — and does not require culture in uncomplicated cases, per AAD guidelines.

For localized non-bullous impetigo, first-line topical treatment is mupirocin 2% ointment applied three times daily for 5 days (generic ~$15–$25 with GoodRx). For extensive or bullous impetigo, oral cephalexin 500 mg four times daily for 7 days (~$10–$20 with GoodRx) is first-line. For suspected CA-MRSA (bullous or purulent), TMP-SMX DS twice daily is recommended per IDSA SSTI guideline (~$8–$15 with GoodRx). Prescription costs at pharmacy are separate from the TeleDirectMD visit fee ($79).

No. California B&P Code §2290.5 does not require a prior in-person visit. A California-licensed physician can evaluate impetigo lesions through a synchronous video visit — the patient shows the affected area on camera. This is particularly practical for impetigo, where the visual appearance guides diagnosis.

Impetigo is highly contagious through direct contact with infected secretions. Per AAD guidelines, the infection is no longer contagious 24–48 hours after starting antibiotic treatment. California school guidelines typically require exclusion until lesions are crusted over or 24 hours after antibiotic initiation. Cover lesions with clean bandages to prevent spreading. Avoid sharing towels, razors, or clothing. Wash hands frequently.

Seek urgent in-person care if impetigo spreads rapidly with fever and systemic illness, if bullous impetigo covers large body surface areas, if you are immunocompromised, if lesions appear near the eye, or if there are signs of deeper skin infection (cellulitis). Rare complications of untreated impetigo include post-streptococcal glomerulonephritis (kidney inflammation) — completing the full antibiotic course is important.

Aetna became an active in-network payor for TeleDirectMD in California effective April 30, 2026. Verify current in-network status directly with Aetna before your visit. Self pay is $79 regardless of insurance status.

TeleDirectMD is not currently enrolled as a Medi-Cal provider. If you have Medi-Cal, you can use the $79 self-pay rate or find a Medi-Cal-enrolled telehealth provider through your managed care plan or California DHCS at dhcs.ca.gov.

California was an early epicenter for community-acquired MRSA (CA-MRSA) — particularly the USA300 strain — beginning in the late 1990s and early 2000s. The California Department of Public Health monitors CA-MRSA in community settings. CA-MRSA commonly causes bullous impetigo and other purulent SSTIs. For bullous or recurrent impetigo with CA-MRSA concern, IDSA SSTI guidelines recommend TMP-SMX DS as first-line — TeleDirectMD applies this California-specific antibiotic stewardship principle.

UnitedHealthcare Commercial was approved for California effective May 29, 2026, covering commercial plans and Medicare Advantage. Excludes Medi-Cal, Individual Exchange, and Navigate/Charter/Core plan types. Verify your specific plan eligibility with UHC before booking.

California AB 744 (2019) requires commercial health plans to reimburse telehealth services on the same basis as in-person services. Parity applies when the provider is already in-network with your specific plan. Currently, Aetna (active April 30, 2026) and UnitedHealthcare Commercial (active May 29, 2026) are in-network in California for TeleDirectMD.

California requires all prescriptions to be issued electronically under Assembly Bill 2789 (effective January 1, 2022). If an antibiotic is appropriate, TeleDirectMD sends an e-prescription electronically to your chosen California pharmacy during or after your visit. Most California pharmacies fill within one to four hours. Starting antibiotics promptly reduces contagious period and prevents complications.